Brain Tumor Diagnosis and Treatment Market by Product (Primary Brain Tumor and Secondary Brain Tumor), by Diagnosis Type (CT Scan, MRI, PET-CT Scan, Molecular Testing, EEG, and Others), and by Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, and Immunotherapy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Global brain tumor diagnosis and treatment market expected to generate revenue of around USD 744 million by the end of 2024, growing at a CAGR of around 8.65% between 2018 and 2024. Brain tumors generally occur in supportive brain tissues. The exact cause of brain tumor is not yet known, and it can occur in any age group.

26-Oct-2018 | Number of pages: 110 | Report Code: ZMR-3468 | Report Format : | Status : Published

Analysis

The brain is the most important organ of the human body, which consists of nerve cells and other supportive tissues. The development of cancerous cells in the brain is known as a brain tumor. There are two major types of brain tumor, namely secondary brain tumor and primary brain tumor. Primary brain tumors can either be malignant or benign, whereas secondary brain tumors are metastatic, i.e., they can spread to other organs as well.

According to CBTRUS (Central Brain Tumor Registry of the United States), in 2016, 80,000 new cases of nonmalignant, primary malignant, and CNS cancers were anticipated to be diagnosed in the U.S. in 2017. The rising incidence of brain tumor among the population is primarily fueling the growth of the global market for brain tumor diagnosis and treatment. The increasing geriatric population, development in diagnostics and treatment equipment, and ongoing research in the development of new technologies to treat cancers are anticipated to fuel the growth of the global brain tumor diagnosis and treatment market in the near future.

Global Brain Tumor Diagnosis and Treatment Market

The brain tumor diagnosis and treatment market are segmented based on product type, diagnosis type, and treatment type. Based on product type, the market for brain tumor diagnosis and treatment is bifurcated into primary brain tumor and secondary brain tumor. Primary brain tumors are further sub-segmented into gliomas, meningioma, pituitary tumors, astrocytomas, and other primary brain tumors. The primary brain tumor segment is anticipated to dominate the market during the forecast period, owing to the increase in the occurrences of meningioma cancer. Based on diagnosis type, this market is classified into MRI, CT scan, PET-CT scan, EEG, molecular testing, and others. The CT scan segment is anticipated to lead the diagnosis type segment for this market. The treatment type segment of the brain tumor diagnosis and treatment market includes chemotherapy, radiation therapy, targeted therapy, surgery, and immunotherapy. The surgery segment is estimated to dominate the brain tumor diagnosis and treatment market during the forecast period.

North America is projected to dominate the market during the forecast period, due to a rapid increase in research related to the development of techniques to treat brain tumor and increase in awareness about the treatments and management of brain tumor among the population. Europe is expected to show the highest growth owing to the rise in government initiatives, an increase in the prevalence of brain tumors in countries like the UK, and the growth of the geriatric population. Additionally, the growing awareness about brain tumor treatments and an increase in the investments made by companies are other factors fueling the growth of the brain tumor diagnosis and treatment market.

The main players in the brain tumor diagnosis and treatment market are GE Healthcare, Merck & Co. Inc., AstraZeneca, Hitachi Medical Corporation, Carestream Health, Pfizer, Inc., Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, and Shimadzu Corporation. These companies focus on entering agreements and partnership to develop products and provide quality products. For instance, in 2016, Pfizer Inc. acquired Medivation, a company which is involved in the development of drugs used for treating cancer.


Related Reports

Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Neuromonitoring devices, Respiratory monitoring devices, Anesthesia monitor, Hemodynamic monitoring devices, Fetal and neonatal monitoring, Multiparameter monitoring devices and Others), by Type (Wireless Sensor Technology, MHealth, Telehealth, Wearable Devices, and Others), and End use (Hospitals, Ambulatory surgical centers, Homecare settings, and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5368 | Report Format:

The report covers forecast and analysis for the Patient Monitoring Devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Patient Mon...Read More

COVID-19 Drug Delivery Devices Market by Product (Prefilled Syringes, Needle-Free Injectors, Inhalers, Patches, and Others), by Route of Administration (Parenteral, Nasal, and Dermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5367 | Report Format:

The report covers forecast and analysis for the COVID-19 drug delivery devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the COVID-1...Read More

Face Shield Market by Material (Cellulose Acetate, Polycarbonate, and Others), and End-User (Oil & Gas, Construction, Healthcare, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5366 | Report Format:

The report covers forecast and analysis for the face shield market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the face shield market along w...Read More

Medical Protective Goggles Market by Type (Reusable Protective Goggles and Disposable Protective Goggles), and End-User (Clinics, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5365 | Report Format:

The report covers forecast and analysis for the medical protective goggles market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the medical pro...Read More

Request Free Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.